Spectrofluorimetric determination of aliskiren in dosage forms and urine

Luminescence

Volumn 27, Issue 6, 2012, Pages 489-494

  Aydoǧmuş, Zeynep ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

aliskiren; fluorescamine; spectrofluorimetry; tablets; urine

Indexed keywords

BODY FLUIDS;

ALISKIREN; DOSAGE FORMS; FLUORESCAMINES; HUMAN URINE; SIMPLE++; SPECTROFLUORIMETRIC DETERMINATION; SPECTROFLUORIMETRIC METHODS; SPECTROFLUORIMETRY; TABLET; URINE;

FLUORESCENCE;

ALISKIREN; AMIDE; ANTIHYPERTENSIVE AGENT; BORIC ACID; BUFFER; FLUORESCAMINE; FUMARIC ACID DERIVATIVE; TABLET;

ARTICLE; CALIBRATION; CHEMISTRY; DRUG STABILITY; FEMALE; FLUORESCENCE; HUMAN; METHODOLOGY; PH; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SPECTROFLUOROMETRY; TABLET; TEMPERATURE; TIME; URINE; ANALYSIS; PROCEDURES;

AMIDES; ANTIHYPERTENSIVE AGENTS; BORATES; BUFFERS; CALIBRATION; DRUG STABILITY; FEMALE; FLUORESCAMINE; FLUORESCENCE; FUMARATES; HUMANS; HYDROGEN-ION CONCENTRATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE; TABLETS; TEMPERATURE; TIME FACTORS;

EID: 84871733860     PISSN: 15227235     EISSN: 15227243     Source Type: Journal    
DOI: 10.1002/bio.1381     Document Type: Conference Paper

References (22)

1. Huang HL, Vaidyanathan S, Yeh CM, Bizot MN, Dieterich HA, Dole WP, Howard D,. Effect of aliskiren, an oral direct renin inhibitor, on the pharmacokinetics and pharmacodynamics of a single dose of acenocoumarol in healthy volunteers. Curr Med Res Opin 2008; 24: 2449-56.
2. Limoges D, Dieterich HA, Yeh CM, Vaidyanathan S, Howard D, Dole WP,. A study of dose-proportionality in the pharmacokinetics of the oral direct renin inhibitor aliskiren in healthy subjects. Int J Clin Pharmacol Ther 2008; 46: 252-8.
3. Zhao C, Vaidyanathan S, Yeh CM, Maboudian M, Armin Dieterich H,. Aliskiren exhibits similar pharmacokinetics in healthy volunteers and patients with type 2 diabetes mellitus. Clin Pharmacokinet 2006; 45: 1125-34.
4. Lefevre G, Gauron S,. Automated quantitative determination of the new renin inhibitor CGP 60536 by high-performance liquid chromatography. J Chromatogr B 2000; 738: 129-36.
5. Dieterle W, Corynen S, Vaidyanathan S, Mann J,. Pharmacokinetic interactions of the oral renin inhibitor aliskiren with lovastatin, atenolol, celecoxib and cimetidine. Int J Clin Pharmacol Ther 2005; 43: 527-35.
6. Vaidyanathan S, Valencia J, Kemp C, Zhao C, Yeh CM, Bizot MN, Denouel J, Dieterich HA, Dole WP,. Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers. Int J Clin Pract 2006; 60: 1343-56.
7. Ayalasomayajula S, Tchaloyan S, Yeh CM, Dieterich MN, Howard D, Dole WP,. A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with allopurinol, celecoxib and cimetidine in healthy subjects. Curr Med Res Opin 2008; 224: 717-26.
8. Vaidyanathan S, Bigler H, Yeh CM, Bizot MN, Dieterich HA, Howard D, Dole WP,. Pharmacokinetics of the oral direct renin inhibitor aliskiren alone and in combination with irbesartan in renal impairment. Clin Pharmacokinet 2007; 46: 661-75.
9. Vaidyanathan S, Maboudian M, Warren V, Yeh CM, Dieterich HA, Howard D, Dole WP,. A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects. Curr Med Res Opin 2008; 24: 2313-26.
10. Lefévre G, Duval M, Poncin A,. Direct micro-radioimmunoassay of the new renin inhibitor CGP 60536. J Immunoassay 2000; 21: 65-84.
11. Wrasse-Sangoi M, Secretti LT, Diefenbach IF, Rolim CMB, Sangoi MD,. Development and validation of an UV spectrophotometric method for the determination of aliskiren in tablets. Quim Nova 2010; 33: 1330-34.
12. Pachauri S, Paliwal S, Srinivas KS, Singh Y, Jain V,. Development and validation of HPLC method for analysis of some antihypertensive agents in their pharmaceutical dosage forms. J Pharm Sci and Res 2010; 2: 459-64.
13. Aydoǧmuş Z, Sarbox drawings light down and left F, Ulu ST,. Spectrofluorimetric determination of aliskiren in tablets and spiked human plasma through derivatization with dansyl Chloride. J Fluoresc 2011. doi: 10.1007/s10895-011-0988-y.
14. Martin MA, Lin B, del Castillo B,. The use of fluorescent probes in pharmaceutical analysis. J Pharm Biomed Anal 1988; 6: 573-83.
15. El-Enany N,. Spectrofluorometric determination of fluvoxamine in dosage forms, spiked plasma, and real human plasma by derivatization with fluorescamine. J AOAC Int 2007; 90: 376-83.
16. Salisbury CD, Sweet JC, Munro R,. Determination of sulfonamide residues in the tissues of food animals using automated precolumn derivatization and liquid chromatography with fluorescence detection. J AOAC Int 2004; 87: 1264-8.
17. Aydoǧmuş Z,. Simple and sensitive spectrofluorimetric method for the determination of oseltamivir phosphate in capsules through derivatization with fluorescamine. J Fluoresc 2009; 19: 673-9.
18. Adamou R, Coly A, Douabalé SE, Saleck ML, Gaye-Seye MD, Tine A,. Fluorimetric determination of histamine in fish using micellar media and fluorescamine as labelling reagent. J Fluoresc 2005; 15: 679-88.
19. Eggenreich K, Zach E, Beck H, Wintersteiger R,. Determination of 4-amino-m-cresol and 5-amino-o-cresol by high performance liquid chromatography and fluorescence derivatization using fluorescamine. J Biochem Biophys Methods 2004; 61: 35-46.
20. ICH Steering Committees. November 1996. Validation of analytical procedures: methodology. ICH harmonized tripartite guideline. In International Conference of Harmonization, Geneva, Switzerland.
21. Sangoi MS, Wrasse-Sangoi M, Oliveira PR, Rolim CM, Steppe M,. Simultaneous determination of aliskiren and hydrochlorothiazide from their pharmaceutical preparations using a validated stability-indicating MEKC method. J Sep Sci 2011; 34: 1859-66.
22. Waldmeier F, Glaenzel U, Wirz B, Oberer L, Schmid D, Seiberling M, Valencia J, Riviere GJ, End P, Vaidyanathan S,. Absorption, distribution, metabolism, and elimination of the direct renin inhibitor aliskiren in healthy volunteers. Drug Metab Dispos 2007; 35: 1418-28.